| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
0.435 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
TRIP13 |
TRIP13: Thyroid receptor-interacting protein 13 |
0.435 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
0.435 |
Evidence |
|
| KAL1 |
KAL1, ADMLX, KAL, KALIG1: Anosmin-1 precursor |
PTPRZ1 |
IPI00291099 |
0.435 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
0.435 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.435 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
0.435 |
Evidence |
|
| PNLIP |
PNLIP: Pancreatic triacylglycerol lipase precursor |
MEP1A |
MEP1A: Meprin A subunit alpha precursor |
0.435 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
0.435 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
0.435 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
ITGB7 |
ITGB7: Integrin beta-7 precursor |
0.435 |
Evidence |
|
| VIL2 |
IPI00479359 |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
0.435 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
SORL1 |
SORL1: Sortilin-related receptor precursor |
0.435 |
Evidence |
|
| LCP1 |
LCP1, PLS2: Plastin-2 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
0.435 |
Evidence |
|
| LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
0.435 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
0.435 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
LAMA2 |
LAMA2: Uncharacterized protein LAMA2 |
0.435 |
Evidence |
|
| SNRPC |
SNRPC: U1 small nuclear ribonucleoprotein C |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.435 |
Evidence |
|
| CD63 |
CD63, MLA1, TSPAN30: CD63 antigen |
LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
0.435 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
ANAPC5 |
ANAPC5, APC5: Anaphase-promoting complex subunit 5 |
0.435 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
0.435 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
USP10 |
USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 |
0.435 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.435 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.435 |
Evidence |
|
| MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
0.435 |
Evidence |
|